These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20713089)

  • 1. Development of a simple system for screening anti-hepatitis C virus drugs utilizing mutants capable of vigorous replication.
    Yu L; Aoki C; Shimizu Y; Shimizu K; Hou W; Yagyu F; Wen X; Oshima M; Iwamoto A; Gao B; Liu W; Gao GF; Kitamura Y
    J Virol Methods; 2010 Nov; 169(2):380-4. PubMed ID: 20713089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel luciferase and GFP dual reporter virus for rapid and convenient evaluation of hepatitis C virus replication.
    Wu Y; Liao Q; Yang R; Chen X; Chen X
    Virus Res; 2011 Feb; 155(2):406-14. PubMed ID: 21144873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a robust luciferase reporter 1b/2a hepatitis C virus (HCV) for characterization of early stage HCV life cycle inhibitors.
    Chan K; Robinson M; Yang H; Cornew S; Delaney Iv WE
    Antiviral Res; 2013 Apr; 98(1):85-92. PubMed ID: 23376631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant replication-competent hepatitis C virus expressing Azami-Green, a bright green-emitting fluorescent protein, suitable for visualization of infected cells.
    Hou W; Aoki C; Yu L; Wen X; Xue Y; Gao B; Liu W; Gao GF; Iwamoto A; Kitamura Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):7-11. PubMed ID: 18786508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
    Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses.
    Liu S; Xiao L; Nelson C; Hagedorn CH
    PLoS One; 2012; 7(9):e44965. PubMed ID: 23028707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renilla luciferase-based quantitation of Potato virus A infection initiated with Agrobacterium infiltration of N. benthamiana leaves.
    Eskelin K; Suntio T; Hyvärinen S; Hafren A; Mäkinen K
    J Virol Methods; 2010 Mar; 164(1-2):101-10. PubMed ID: 20026122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
    Nozaki A; Morimoto M; Kondo M; Oshima T; Numata K; Fujisawa S; Kaneko T; Miyajima E; Morita S; Mori K; Ikeda M; Kato N; Tanaka K
    Arch Virol; 2010 Apr; 155(4):601-5. PubMed ID: 20204428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation systems for anti-HCV drugs.
    Moriishi K; Matsuura Y
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
    Zou G; Xu HY; Qing M; Wang QY; Shi PY
    Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell-based bicistronic lentiviral reporter system for identification of inhibitors of the hepatitis C virus internal ribosome entry site.
    Lourenço S; Boni S; Furling D; Cosset FL; Cahour A
    J Virol Methods; 2009 Jun; 158(1-2):152-9. PubMed ID: 19428584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase.
    Liu S; Nelson CA; Xiao L; Lu L; Seth PP; Davis DR; Hagedorn CH
    Antiviral Res; 2011 Jan; 89(1):54-63. PubMed ID: 21075143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
    Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
    Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel HCV replication mouse model using human hepatocellular carcinoma xenografts.
    Guévin C; Lamarre A; Labonté P
    Antiviral Res; 2009 Oct; 84(1):14-22. PubMed ID: 19622372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant.
    Kaul A; Woerz I; Meuleman P; Leroux-Roels G; Bartenschlager R
    J Virol; 2007 Dec; 81(23):13168-79. PubMed ID: 17881454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermostable hepatitis C virus JFH1-derived variant isolated by adaptation to Huh7.5.1 cells.
    Shirasago Y; Fukazawa H; Aizaki H; Suzuki T; Suzuki T; Sugiyama K; Wakita T; Hanada K; Abe R; Fukasawa M
    J Gen Virol; 2018 Oct; 99(10):1407-1417. PubMed ID: 30045785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
    Hao W; Duggal R
    Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring the antiviral effect of alpha interferon on individual cells.
    Kim CS; Jung JH; Wakita T; Yoon SK; Jang SK
    J Virol; 2007 Aug; 81(16):8814-20. PubMed ID: 17537862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication.
    Dansako H; Ikeda M; Abe K; Mori K; Takemoto K; Ariumi Y; Kato N
    Virus Res; 2008 Oct; 137(1):72-9. PubMed ID: 18602954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.
    Jensen TB; Gottwein JM; Scheel TK; Hoegh AM; Eugen-Olsen J; Bukh J
    J Infect Dis; 2008 Dec; 198(12):1756-65. PubMed ID: 19032070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.